Evidence map›Paper›PMID 27533920›Full record

ArticleOrganic & biomolecular chemistry2016

Total synthesis of fellutamides, lipopeptide proteasome inhibitors. More sustainable peptide bond formation.

Michael C Pirrung, Fa Zhang, Sudhakar Ambadi, Y Gangadhara Rao

Erratum issuedAbstract read
In one paragraph

Article in Organic & biomolecular chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Michael C PirrungDepartment of Chemistry, University of California, Riverside, CA 92521, USA.
Fa Zhang
Sudhakar Ambadi
Y Gangadhara Rao

Funding

Sustainable Synthesis of EnfuvirtideR21AI106597 · NIAID · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI PIRRUNG, MICHAEL C · 2013 to 2014
$392k
NIAID NIH HHS R21 AI106597
6 · The paper itself

Abstract

Solution-phase syntheses of three bioactive natural products of mixed polypeptide-polyketide biogenesis, fellutamides A, B, and C, have been achieved. Three peptide bonds are generated without the use of coupling reagents in each synthesis of the fellutamides, which act against proteasomes.

Indexed as

Biological ProductsChemistry Techniques, SyntheticLipopeptidesMolecular StructureOligopeptidesProteasome InhibitorsSolutionsBiological Productsfellutamide Afellutamide Bfellutamide CLipopeptidesOligopeptidesProteasome InhibitorsSolutions

Identifiers

PMID27533920
PMCPMC5303010

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.